{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:48:53Z","timestamp":1773683333069,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T00:00:00Z","timestamp":1417132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00432-014-1882-1","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T18:35:02Z","timestamp":1417458902000},"page":"1025-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model"],"prefix":"10.1007","volume":"141","author":[{"given":"Ke-Wang","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hay","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Gar-Lee","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia Kin-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Pui","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Chung","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Evdokiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara Bik-San","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,28]]},"reference":[{"key":"1882_CR1","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/0008-5472.CAN-05-1145","volume":"66","author":"S Bettuzzi","year":"2006","unstructured":"Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of principle study. Cancer Res 66:1234\u20131240","journal-title":"Cancer Res"},{"key":"1882_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1749-8546-5-13","volume":"5","author":"SM Chacko","year":"2010","unstructured":"Chacko SM, Thambi PT, Kuttan R, Nishigaki I (2010) Beneficial effects of green tea: a literature review. Chin Med 5:13","journal-title":"Chin Med"},{"key":"1882_CR3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jnci\/djk054","volume":"994","author":"F Daubine","year":"2007","unstructured":"Daubine F, Le Gall C, Gasser J, Green J, Clezardin P (2007) Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. J Natl Cancer Inst 994:322\u2013330","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1882_CR4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/187221312798889310","volume":"6","author":"WL Eliza","year":"2012","unstructured":"Eliza WL, Fai CK, Chung LP (2012) Efficacy of Yun Zhi (Coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. Recent Pat Inflamm Allergy Drug Discov 6(1):78\u201387","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"1882_CR5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S8756-3282(03)00223-0","volume":"33","author":"A Evdokiou","year":"2003","unstructured":"Evdokiou A, Labrinidis A, Bouralexis S, Hay S, Findlay DM (2003) Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis. Bone 33:216\u2013228","journal-title":"Bone"},{"key":"1882_CR6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4161\/cbt.10.6.12611","volume":"10","author":"G Facchini","year":"2010","unstructured":"Facchini G, Caraglia M, Morabito A, Marra M, Piccirillo MC, Bochicchio AM, Striano S, Marra L, Nasti G, Ferrari E, Leopardo D, Vitale G, Gentilini D, Tortoriello A, Catalano A, Budillon A, Perrone F, Iaffaioli RV (2010) Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial. Cancer Biol Ther 10:543\u2013548","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"1882_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/BSR20090143","volume":"31","author":"F Farabegoli","year":"2011","unstructured":"Farabegoli F, Papi A, Orlandi M (2011) (\u2212)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Biosci Rep 31(2):99\u2013108","journal-title":"Biosci Rep"},{"issue":"3","key":"1882_CR8","first-page":"1737","volume":"22","author":"JB Fitzgerald","year":"2006","unstructured":"Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK (2006) Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol 22(3):1737\u20131754","journal-title":"Nat Chem Biol"},{"issue":"6","key":"1882_CR9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/mnfr.201000641","volume":"55","author":"SC Forester","year":"2011","unstructured":"Forester SC, Lambert JD (2011) The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res 55(6):844\u2013854","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"1882_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-824X-5-9","volume":"5","author":"JW Gu","year":"2013","unstructured":"Gu JW, Makey KL, Tucker KB, Chinchar E, Mao X, Pei I, Thomas EY, Miele L (2013) EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1\u03b1 and NF\u03baB, and VEGF expression. Vasc Cell 5(1):9","journal-title":"Vasc Cell"},{"key":"1882_CR11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1196\/annals.1397.046","volume":"1095","author":"YD Hsuuw","year":"2007","unstructured":"Hsuuw YD, Chan WH (2007) Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Ann N Y Acad Sci 1095:428\u2013440","journal-title":"Ann N Y Acad Sci"},{"key":"1882_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.25051","volume":"127","author":"A Labrinidis","year":"2010","unstructured":"Labrinidis A, Hay S, Liapis V, Findlay DM, Evdokiou A (2010) Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model. Int J Cancer 127:345\u2013354","journal-title":"Int J Cancer"},{"key":"1882_CR13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1749-8546-4-25","volume":"4","author":"YC Lam","year":"2009","unstructured":"Lam YC, Cheng CW, Peng H, Law CK, Huang XZ, Bian ZX (2009) Cancer patients\u2019 attitudes toward Traditional Chinese Medicine: a Hong Kong survey. Chinese Med 4:25","journal-title":"Chinese Med"},{"issue":"1","key":"1882_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/mol.109.057877","volume":"77","author":"JH Lee","year":"2010","unstructured":"Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH (2010) Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol Pharmacol 77(1):17\u201325","journal-title":"Mol Pharmacol"},{"issue":"5","key":"1882_CR15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00223-012-9584-7","volume":"90","author":"SH Lee","year":"2012","unstructured":"Lee SH, Kim BJ, Choi HJ, Cho SW, Shin CS, Park SY, Lee YS, Lee SY, Kim HH, Kim GS, Koh JM (2012) (\u2212)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption. Calcif Tissue Int 90(5):404\u2013410","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1882_CR16","first-page":"111","volume":"37","author":"G Liang","year":"2010","unstructured":"Liang G, Tang A, Lin X, Li L, Zhang S, Huang Z, Tang H, Li QQ (2010) Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 37(1):111\u2013123","journal-title":"Int J Oncol"},{"issue":"1","key":"1882_CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2013.07.024","volume":"339","author":"KW Luo","year":"2013","unstructured":"Luo KW, Ko CH, Yue GGL, Lee MY, Siu WS, Lee JK, Shum WT, Fung KP, Leung PC, Li G, Evdokiou A, Lau CBS (2013) Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models. Cancer Lett 339(1):42\u201348","journal-title":"Cancer Lett"},{"issue":"4","key":"1882_CR18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jnutbio.2013.11.013","volume":"25","author":"KW Luo","year":"2014","unstructured":"Luo KW, Ko CH, Yue GGL, Lee JKM, Lee M, Li G, Fung KP, Leung PC, Lau CBS (2014) Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice. J Nutr Biochem 25(4):395\u2013403","journal-title":"J Nutr Biochem"},{"key":"1882_CR19","doi-asserted-by":"crossref","unstructured":"Martin CK, Dirksen WP, Carlton MM, Lanigan LG, Pillai SP, Werbeck JL, Simmons JK, Hildreth BE, London CA, Toribio RE, and Rosol TJ (2013) Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma. Vet Comp Oncol. doi: 10.1111\/vco.12037","DOI":"10.1111\/vco.12037"},{"issue":"11","key":"1882_CR20","first-page":"4851","volume":"32","author":"ME Mazumder","year":"2012","unstructured":"Mazumder ME, Beale P, Chan C, Yu JQ, Huq F (2012) Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells. Anticancer Res 32(11):4851\u20134860","journal-title":"Anticancer Res"},{"issue":"3","key":"1882_CR21","doi-asserted-by":"crossref","first-page":"e60297","DOI":"10.1371\/journal.pone.0060297","volume":"8","author":"S Okamoto","year":"2013","unstructured":"Okamoto S, Jiang Y, Kawamura K, Shingyoji M, Fukamachi T, Tada Y, Takiguchi Y, Tatsumi K, Shimada H, Hiroshima K, Kobayashi H, Tagawa M (2013) Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels. PLoS One 8(3):e60297","journal-title":"PLoS One"},{"key":"1882_CR22","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1158\/1535-7163.MCT-09-0462","volume":"8","author":"PD Ottewell","year":"2009","unstructured":"Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I (2009) Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Mol Cancer Ther 8:2821\u20132832","journal-title":"Mol Cancer Ther"},{"key":"1882_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrclinonc.2010.82","volume":"7","author":"E Pasquier","year":"2011","unstructured":"Pasquier E, Kavallaris M, Andre N (2011) Metronomic chemotherapy: new rationale for new directions. Nat Rev Clin Oncol 7:455\u2013465","journal-title":"Nat Rev Clin Oncol"},{"key":"1882_CR24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jfca.2008.05.002","volume":"21","author":"L Peng","year":"2008","unstructured":"Peng L, Song XH, Shi XG, Li JX, Ye CX (2008) An improved HPLC method for simultaneous determination of phenolic compounds, purine alkaloids and theanine in Camellia species. J Food Compost Anal 21:559\u2013563","journal-title":"J Food Compost Anal"},{"issue":"6","key":"1882_CR25","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.fct.2011.03.033","volume":"49","author":"J Qiao","year":"2011","unstructured":"Qiao J, Gu C, Shang W, Du J, Yin W, Zhu M, Wang W, Han M, Lu W (2011) Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro. Food Chem Toxicol 49(6):1410\u20131415","journal-title":"Food Chem Toxicol"},{"key":"1882_CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2009.06.003","volume":"287","author":"TD Rachner","year":"2010","unstructured":"Rachner TD, Singh SK, Schoppet M, Benad P, Bornhauser M, Ellenrieder V, Ebert R, Jakob F, Hofbauer LC (2010) Zoledronic acid induces apoptosis and changes the TRAIL\/OPG ratio in breast cancer cells. Cancer Lett 287:109\u2013116","journal-title":"Cancer Lett"},{"key":"1882_CR27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/pgmj.2008.076349","volume":"85","author":"P Ryan","year":"2009","unstructured":"Ryan P, Saleh I, Stassen LF (2009) Osteonecrosis of the jaw: a rare and devastating side effect of bisphosphonates. Postgrad Med J 85:674\u2013677","journal-title":"Postgrad Med J"},{"issue":"13","key":"1882_CR28","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.2010.1360","volume":"304","author":"DE Sellmeyer","year":"2010","unstructured":"Sellmeyer DE (2010) Atypical fractures as a potential complication of long-term bisphosphonate therapy. JAMA 304(13):1480\u20131484","journal-title":"JAMA"},{"key":"1882_CR29","first-page":"311","volume":"77","author":"VP Terranova","year":"1986","unstructured":"Terranova VP, Hujanen ES, Martin GR (1986) Basement membrane and the invasive activity of metastatic tumor cells. J Natl Cancer Inst 77:311\u2013316","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"1882_CR30","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4161\/cbt.6.12.4974","volume":"6","author":"RL Thangapazham","year":"2007","unstructured":"Thangapazham RL, Passi N, Maheshwari RK (2007) Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther 6(12):1938\u20131943","journal-title":"Cancer Biol Ther"},{"key":"1882_CR31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","volume":"302","author":"J Wood","year":"2002","unstructured":"Wood J, Bonjean K, Ruetz S, Bellahcene A, Devy L, Foidart JM, Castronovo V, Green JR (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302:1055\u20131061","journal-title":"J Pharmacol Exp Ther"},{"key":"1882_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/msb4100133","volume":"3","author":"P Yeh","year":"2007","unstructured":"Yeh P, Kishony R (2007) Networks from drug\u2013drug surfaces. Mol Syst Biol 3:85","journal-title":"Mol Syst Biol"},{"key":"1882_CR33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","volume":"65","author":"FL Zhang","year":"1996","unstructured":"Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241\u2013269","journal-title":"Annu Rev Biochem"},{"key":"1882_CR34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10549-010-1183-6","volume":"124","author":"X Zhao","year":"2010","unstructured":"Zhao X, Xu X, Guo L, Ragaz J, Guo H, Wu J, Shao Z, Zhu J, Guo X, Chen J, Zhu B, Wang Z, Hu X (2010) Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance. Breast Cancer Res Treat 124:733\u2013743","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1882_CR35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/aps.2011.139","volume":"33","author":"F Zhou","year":"2012","unstructured":"Zhou F, Zhou H, Wang T, Mu Y, Wu B, Guo DL, Zhang XM, Wu Y (2012) Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro. Acta Pharmacol Sin 33(1):120\u2013126","journal-title":"Acta Pharmacol Sin"},{"key":"1882_CR36","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/1535-7163.MCT-09-0745","volume":"8","author":"I Zinonos","year":"2009","unstructured":"Zinonos I, Labrinidis A, Lee M, Liapis V, Hay S, Ponomarev V, Diamond P, Zannettino AC, Findlay DM, Evdokiou A (2009) Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer. Mol Cancer Ther 8:2969\u20132980","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1882-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1882-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1882-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:30:02Z","timestamp":1717594202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1882-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,28]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["1882"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1882-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,28]]}}}